Skip to main content
Erschienen in: Inflammopharmacology 2/2018

15.02.2017 | Original Article

Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia

verfasst von: Jenny Jacob, Bashi M. Babu, Mohind C. Mohan, A. P. Abhimannue, B. Prakash Kumar

Erschienen in: Inflammopharmacology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Tinospora cordifolia (Willd.) Miers ex Hook. f. & Thomson, a known immunomodulatory agent extensively used in ayurveda, has not been effectively validated for the mechanisms involved in immunomodulation and the identification of the active principles. The bioactive fraction of T. cordifolia (TBF) in methanol was used for nitric oxide (NO) radical scavenging activity, lipoxygenase (LOX) and cyclooxygenase (COX) dual inhibition and cytotoxicity studies. Production of the proinflammatory cytokines, tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in dendritic cell (DC) suspensions treated with lipopolysaccharide (LPS) was also studied. The bioactive principles involved were identified with ultra-performance liquid chromatography-quadrupole-time of flight mass spectrometric (UPLC-Q-ToF MS/MS) system. The results indicate significantly higher potency of TBF as compared to positive standards for LOX/COX inhibition with moderate NO radical scavenging activity and the fraction was also found to be non-cytotoxic to monocyte cells. A significant inhibition was also observed in TNF-α and IL-1β production in LPS-treated DC suspensions as compared to standards, rolipram and dexamethasone, respectively. 11 compounds were identified from TBF by MS/MS system. The potent inhibition of LOX and COX enzymes with moderate NO scavenging was indicative of a free radical scavenging-independent mechanism of immunomodulation. Further investigations into the active principles identified would result in the development of lead candidates with potent therapeutic implications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Broderick KE, Feala J, McCulloch A, Paternostro G, Sharma VS, Pilz RB, Boss GR (2006) The nitric oxide scavenger cobinamide profoundly improves survival in a Drosophila melanogaster model of bacterial sepsis. FASEB J 20:1865–1873. doi:10.1096/fj.06-5780com CrossRefPubMed Broderick KE, Feala J, McCulloch A, Paternostro G, Sharma VS, Pilz RB, Boss GR (2006) The nitric oxide scavenger cobinamide profoundly improves survival in a Drosophila melanogaster model of bacterial sepsis. FASEB J 20:1865–1873. doi:10.​1096/​fj.​06-5780com CrossRefPubMed
Zurück zum Zitat Chang DM, Baptiste P, Schur PH (1990) The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 17(9):1148–1157PubMed Chang DM, Baptiste P, Schur PH (1990) The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 17(9):1148–1157PubMed
Zurück zum Zitat Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM (1994) Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 91:11202–11206CrossRefPubMedPubMedCentral Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM (1994) Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 91:11202–11206CrossRefPubMedPubMedCentral
Zurück zum Zitat Fiorucci S, Meli R, Bucci M, Cirino G (2001) Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 62:1433–1438CrossRefPubMed Fiorucci S, Meli R, Bucci M, Cirino G (2001) Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 62:1433–1438CrossRefPubMed
Zurück zum Zitat Gheorghe KR, Korotkova M, Catrina AI, Backman L, Af Klint E, Claesson H-E, Rådmark O, Jakobsson P-J (2009) Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Res Ther 11:R83. doi:10.1186/ar2717 CrossRefPubMedPubMedCentral Gheorghe KR, Korotkova M, Catrina AI, Backman L, Af Klint E, Claesson H-E, Rådmark O, Jakobsson P-J (2009) Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Res Ther 11:R83. doi:10.​1186/​ar2717 CrossRefPubMedPubMedCentral
Zurück zum Zitat Hsi LC, Wilson LC, Eling TE (2002) Opposing effects of 15-Lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate: alteration in peroxisome proliferator-activated receptor. J Biol Chem 277:40549–40556. doi:10.1074/jbc.M203522200 CrossRefPubMed Hsi LC, Wilson LC, Eling TE (2002) Opposing effects of 15-Lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate: alteration in peroxisome proliferator-activated receptor. J Biol Chem 277:40549–40556. doi:10.​1074/​jbc.​M203522200 CrossRefPubMed
Zurück zum Zitat Jacob J, Kumar PB (2013) Ayurvedic herb, Tinospora cordifolia: validation of anti-inflammatory and immunomodulatory activity by effect on inflammatory mediators, TNF-α and lipoxygenase isozymes. JPRBioMedRx Int J 1(9):861–864 Jacob J, Kumar PB (2013) Ayurvedic herb, Tinospora cordifolia: validation of anti-inflammatory and immunomodulatory activity by effect on inflammatory mediators, TNF-α and lipoxygenase isozymes. JPRBioMedRx Int J 1(9):861–864
Zurück zum Zitat Jacob J, Prakash KB, Abhimannue AP, Mohan M, Babu BM (2014) Inhibition of lipoxygenase enzymes by extracts of Tinospora cordifolia: a study of enzyme kinetics. J Nat Prod 7:203–209 Jacob J, Prakash KB, Abhimannue AP, Mohan M, Babu BM (2014) Inhibition of lipoxygenase enzymes by extracts of Tinospora cordifolia: a study of enzyme kinetics. J Nat Prod 7:203–209
Zurück zum Zitat Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81(1):237–244CrossRefPubMedPubMedCentral Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81(1):237–244CrossRefPubMedPubMedCentral
Zurück zum Zitat Korhonen R, Hömmö T, Keränen T, Laavola M, Hämäläinen M, Vuolteenaho K, Lehtimäki L, Kankaanranta H, Moilanen E (2013) Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1. Br J Pharmacol 169(7):1525–1536CrossRefPubMedPubMedCentral Korhonen R, Hömmö T, Keränen T, Laavola M, Hämäläinen M, Vuolteenaho K, Lehtimäki L, Kankaanranta H, Moilanen E (2013) Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1. Br J Pharmacol 169(7):1525–1536CrossRefPubMedPubMedCentral
Zurück zum Zitat Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA (1998) Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160:4090–4097PubMed Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA (1998) Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160:4090–4097PubMed
Zurück zum Zitat Marjanović M, Kralj M, Supek F, Frkanec L, Piantanida I, Smuc T, Tusek-Bozić L (2007) Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores. J Med Chem 50:1007–1018. doi:10.1021/jm061162u CrossRefPubMed Marjanović M, Kralj M, Supek F, Frkanec L, Piantanida I, Smuc T, Tusek-Bozić L (2007) Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores. J Med Chem 50:1007–1018. doi:10.​1021/​jm061162u CrossRefPubMed
Zurück zum Zitat Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring MB, Gabay C (2002) Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res Therapy 4(3):226–231CrossRef Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring MB, Gabay C (2002) Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res Therapy 4(3):226–231CrossRef
Zurück zum Zitat Parente L (2001) Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol 28:2375–2382PubMed Parente L (2001) Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol 28:2375–2382PubMed
Zurück zum Zitat Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994) Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890–896. doi:10.1038/ki.1994.117 CrossRefPubMed Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994) Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890–896. doi:10.​1038/​ki.​1994.​117 CrossRefPubMed
Zurück zum Zitat Pinto NB, Morais TC, Carvalho KMB, Silva CR, Andrade GM, Brito GAC, Veras ML, Pessoa ODL, Rao VS, Santos FA (2010) Topical anti-inflammatory potential of Physalin E from Physalis angulata on experimental dermatitis in mice. Phytomedicine 17(10):740–743. doi:10.1016/j.phymed.2010.01.006 CrossRefPubMed Pinto NB, Morais TC, Carvalho KMB, Silva CR, Andrade GM, Brito GAC, Veras ML, Pessoa ODL, Rao VS, Santos FA (2010) Topical anti-inflammatory potential of Physalin E from Physalis angulata on experimental dermatitis in mice. Phytomedicine 17(10):740–743. doi:10.​1016/​j.​phymed.​2010.​01.​006 CrossRefPubMed
Zurück zum Zitat Singh BP, Deepa (2015) Concept of immunomodulation in ayurveda and some immunomodulatory herbs. Int Ayurvedic Med J 3(7):2205–2212 Singh BP, Deepa (2015) Concept of immunomodulation in ayurveda and some immunomodulatory herbs. Int Ayurvedic Med J 3(7):2205–2212
Zurück zum Zitat Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low-affinity’ phosphodiesterase 4 conformer. Br J Pharmacol 118(3):649–658CrossRefPubMedPubMedCentral Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low-affinity’ phosphodiesterase 4 conformer. Br J Pharmacol 118(3):649–658CrossRefPubMedPubMedCentral
Zurück zum Zitat Verma R, Juvekar AR, Gopalkrishnan R (2006) Bioassay guided purification of an immunomodulatory polysaccharide from roots of Tinospora cordifolia. Planta Medica 72(11):P_002. doi:10.1055/s-2006-949802 Verma R, Juvekar AR, Gopalkrishnan R (2006) Bioassay guided purification of an immunomodulatory polysaccharide from roots of Tinospora cordifolia. Planta Medica 72(11):P_002. doi:10.​1055/​s-2006-949802
Zurück zum Zitat Wang P, Myers JG, Wu P, Cheewatrakoolpong B, Egan RW, Billah MM (1997) Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun 234:320–324CrossRefPubMed Wang P, Myers JG, Wu P, Cheewatrakoolpong B, Egan RW, Billah MM (1997) Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun 234:320–324CrossRefPubMed
Metadaten
Titel
Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia
verfasst von
Jenny Jacob
Bashi M. Babu
Mohind C. Mohan
A. P. Abhimannue
B. Prakash Kumar
Publikationsdatum
15.02.2017
Verlag
Springer International Publishing
Erschienen in
Inflammopharmacology / Ausgabe 2/2018
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-017-0319-2

Weitere Artikel der Ausgabe 2/2018

Inflammopharmacology 2/2018 Zur Ausgabe